Quarterly report pursuant to Section 13 or 15(d)

Stockholders Equity (Details) - Part-2

v3.24.3
Stockholders Equity (Details) - Part-2 - $ / shares
Sep. 16, 2024
Jul. 11, 2024
Jul. 09, 2024
Sep. 30, 2024
[1]
Mar. 15, 2024
Dec. 31, 2023
[1]
Stockholders Equity [Line Items]            
Total number of fully-diluted shares     15.00%      
Common stock, shares outstanding     7,800,000 18,176,602   4,723,320
Stock Issued During Period, Shares, Restricted Stock Award, Gross 155,429          
Restricted stock unit fair value (in Dollars per share) $ 0.99          
Options granted exercise price (in Dollars per share)   $ 3.63        
PIPE [Member]            
Stockholders Equity [Line Items]            
Aggregate warrants         952,381  
Agents Warrants [Member] | PIPE [Member]            
Stockholders Equity [Line Items]            
Exercise price (in Dollars per share)         $ 2.31  
Board of Directors [Member]            
Stockholders Equity [Line Items]            
Grant of options   1,567,795        
[1] All share amounts have been retroactively adjusted to reflect a 1-for-10 reverse share split as discussed in Note 10A.